Zydus Cadila gets USFDA approval for antiviral drug
New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Acyclovir injection, used to treat infections caused by herpes viruses, in the US market.
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Acyclovir Sodium Injection, 500 mg/10 mL and 1,000 mg/20mL single-dose vials, Cadila Healthcare said in a BSE filing.
The approved drug will be produced at the group's formulation manufacturing facility at Moriya, Ahmedabad, it added.
The group now has nearly 216 approvals from the USFDA and so far filed 330 abbreviated new drug applications (ANDAs), Cadila Healthcare said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd